![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
New UK primary care clinical trials company Interface Clinical Research to offer a more effective model
New clinical trials company, Interface Clinical Research, outlined a new model for running primary care clinical trials at their launch yesterday at the Royal...
Clinical Trials
Pluristem Completes Patient Enrollment in a Large Multinational Phase II Trial in Intermittent Claudication
Pluristem Therapeutics Inc , a leading developer of placenta-based cell therapy products, today announced that it has completed enrollment of all 172 patients in a multinational...
Clinical Trials
Visterra doses first patient in phase IIa trial for VIS410 for Influenza A
Visterra, Inc , a clinical-stage biopharmaceutical company announced that the first patient was dosed in a Phase 2a clinical trial of VIS410, a monoclonal antibody...
Clinical Trials
Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
Valeant Pharmaceuticals International, Inc. announced positive results from a second confirmatory pivotal Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety...
Clinical Trials
Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform
The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings...
Clinical Trials
Renova Therapeutics selects Worldwide Clinical Trials as its CRO for RT-100 AC6 gene transfer
Renova  Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes. Announced that it has...
Clinical Trials
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry EyeÂ
Sun Pharma (SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies), announced successful Phase 3 confirmatory...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read